View the DOXYCAP registration information details.
Back to drug list
ItemsDrug Registration information
ID306
No306
Brand NameDOXYCAP
IngredientsDOXYCYCLINE HYDROCHLORIDE/HYCLATE 100 MG
Dosage FormCAPSULE
Primary PackagingBLISTERPACK
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsRICKETTSIAL INFECTIONS, INCLUDING TYPHUS, ROCKY MOUNTAIN SPOTTED FEVER AND Q FEVER. CHLAMYDIAL INFECTIONS, INCLUDING PSITTACOSIS. MYCOPLASMA INFECTIONS, BRUCELLOSIS AND PLAGUE. TULARAEMIA, CHRONIC BRONCHITIS. CHOLERA, RELAPSING FEVER, LEPTOSPIROSIS AND EARLY STAGE OF LYME DISEASE, BALANTIDIASIS, AMOEBIC DYSENTERY. SYPHILIS, YAWS, GONORRHEA, ACTINOMYCOSIS, ANTHRAX.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionLIGHT GREEN AND PINK CAPSULE WITH DXY 100 PRINTED ON ONE END AND HD PRINTED ON THE OTHER, WITH YELLOW FILLED MATERIAL CAPSULE SIZE:2
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No04 I 4687/19
FDD Registration Date07/07/2025
Expiry Date06/07/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA